Annual CFO:
-$176.53M-$154.10M(-686.97%)Summary
- As of today, CDTX annual cash from operations is -$176.53 million, with the most recent change of -$154.10 million (-686.97%) on December 31, 2024.
- During the last 3 years, CDTX annual cash from operations has fallen by -$151.30 million (-599.64%).
- CDTX annual cash from operations is now -16744.75% below its all-time high of -$1.05 million, reached on December 31, 2013.
Performance
CDTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$40.96M-$19.01M(-86.61%)Summary
- As of today, CDTX quarterly cash from operations is -$40.96 million, with the most recent change of -$19.01 million (-86.61%) on June 30, 2025.
- Over the past year, CDTX quarterly cash from operations has increased by +$62.82 million (+60.53%).
- CDTX quarterly cash from operations is now -246.43% below its all-time high of $27.97 million, reached on September 30, 2022.
Performance
CDTX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$129.02M+$62.82M(+32.75%)Summary
- As of today, CDTX TTM cash from operations is -$129.02 million, with the most recent change of +$62.82 million (+32.75%) on June 30, 2025.
- Over the past year, CDTX TTM cash from operations has dropped by -$4.24 million (-3.40%).
- CDTX TTM cash from operations is now -31368.29% below its all-time high of -$410.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CDTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -687.0% | +60.5% | -3.4% |
| 3Y3 Years | -599.6% | -246.1% | -107.0% |
| 5Y5 Years | -518.7% | -191.1% | -120.6% |
CDTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -687.0% | at low | -246.4% | +60.5% | >-9999.0% | +32.8% |
| 5Y | 5-Year | -687.0% | at low | -246.4% | +60.5% | >-9999.0% | +32.8% |
| All-Time | All-Time | >-9999.0% | at low | -246.4% | +60.5% | >-9999.0% | +32.8% |
CDTX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$40.96M(-86.6%) | -$129.02M(+32.7%) |
| Mar 2025 | - | -$21.95M(+25.4%) | -$191.84M(-8.7%) |
| Dec 2024 | -$176.53M(-687.0%) | -$29.41M(+19.8%) | -$176.53M(-10.4%) |
| Sep 2024 | - | -$36.70M(+64.6%) | -$159.84M(-28.1%) |
| Jun 2024 | - | -$103.78M(-1462.0%) | -$124.78M(-586.4%) |
| Mar 2024 | - | -$6.64M(+47.8%) | -$18.18M(+19.0%) |
| Dec 2023 | -$22.43M(+21.2%) | -$12.72M(-678.6%) | -$22.43M(+27.0%) |
| Sep 2023 | - | -$1.63M(-157.9%) | -$30.71M(-2679.4%) |
| Jun 2023 | - | $2.82M(+125.9%) | -$1.10M(+93.0%) |
| Mar 2023 | - | -$10.90M(+48.1%) | -$15.76M(+44.6%) |
| Dec 2022 | -$28.47M(-12.8%) | -$21.00M(-175.1%) | -$28.47M(-27.2%) |
| Sep 2022 | - | $27.97M(+336.3%) | -$22.38M(+64.1%) |
| Jun 2022 | - | -$11.84M(+49.9%) | -$62.32M(-32.5%) |
| Mar 2022 | - | -$23.61M(-58.4%) | -$47.05M(-86.5%) |
| Dec 2021 | -$25.23M(+53.6%) | -$14.91M(-24.5%) | -$25.23M(-17.6%) |
| Sep 2021 | - | -$11.97M(-448.0%) | -$21.45M(+9.0%) |
| Jun 2021 | - | $3.44M(+291.9%) | -$23.56M(+42.6%) |
| Mar 2021 | - | -$1.79M(+83.9%) | -$41.08M(+24.5%) |
| Dec 2020 | -$54.41M(-90.7%) | -$11.13M(+21.0%) | -$54.41M(+7.0%) |
| Sep 2020 | - | -$14.08M(-0.1%) | -$58.48M(-110.5%) |
| Jun 2020 | - | -$14.07M(+7.0%) | -$27.78M(-4.8%) |
| Mar 2020 | - | -$15.13M(+0.5%) | -$26.51M(+7.1%) |
| Dec 2019 | -$28.53M | -$15.20M(-191.4%) | -$28.53M(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $16.62M(+229.8%) | -$27.00M(+52.1%) |
| Jun 2019 | - | -$12.81M(+25.3%) | -$56.40M(+4.6%) |
| Mar 2019 | - | -$17.15M(-25.5%) | -$59.13M(-4.3%) |
| Dec 2018 | -$56.70M(-13.6%) | -$13.67M(-6.9%) | -$56.70M(-7.9%) |
| Sep 2018 | - | -$12.78M(+17.7%) | -$52.53M(+2.0%) |
| Jun 2018 | - | -$15.53M(-5.5%) | -$53.61M(-7.0%) |
| Mar 2018 | - | -$14.72M(-55.1%) | -$50.11M(-0.4%) |
| Dec 2017 | -$49.91M(-25.5%) | -$9.49M(+31.6%) | -$49.91M(+4.3%) |
| Sep 2017 | - | -$13.87M(-15.3%) | -$52.14M(-13.4%) |
| Jun 2017 | - | -$12.03M(+17.1%) | -$45.96M(-5.9%) |
| Mar 2017 | - | -$14.52M(-23.8%) | -$43.40M(-9.1%) |
| Dec 2016 | -$39.77M(-53.2%) | -$11.73M(-52.5%) | -$39.77M(-14.3%) |
| Sep 2016 | - | -$7.69M(+18.8%) | -$34.78M(-1.1%) |
| Jun 2016 | - | -$9.47M(+13.0%) | -$34.40M(-11.7%) |
| Mar 2016 | - | -$10.89M(-61.6%) | -$30.79M(-18.6%) |
| Dec 2015 | -$25.96M(-236.7%) | -$6.74M(+7.7%) | -$25.96M(-15.9%) |
| Sep 2015 | - | -$7.30M(-24.5%) | -$22.39M(-22.3%) |
| Jun 2015 | - | -$5.87M(+3.1%) | -$18.31M(-37.2%) |
| Mar 2015 | - | -$6.05M(-90.8%) | -$13.35M(-73.2%) |
| Dec 2014 | -$7.71M(-635.7%) | -$3.17M(+1.6%) | -$7.71M(-69.9%) |
| Sep 2014 | - | -$3.22M(-256.6%) | -$4.54M(-245.4%) |
| Jun 2014 | - | -$904.00K(-120.5%) | -$1.31M(-220.5%) |
| Mar 2014 | - | -$410.00K | -$410.00K |
| Dec 2013 | -$1.05M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Cidara Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Cidara Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of CDTX is -$176.53M
What is the all-time high annual cash from operations for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual cash from operations is -$1.05M
What is Cidara Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, CDTX annual cash from operations has changed by -$154.10M (-686.97%)
What is Cidara Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of CDTX is -$40.96M
What is the all-time high quarterly cash from operations for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly cash from operations is $27.97M
What is Cidara Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, CDTX quarterly cash from operations has changed by +$62.82M (+60.53%)
What is Cidara Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of CDTX is -$129.02M
What is the all-time high TTM cash from operations for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM cash from operations is -$410.00K
What is Cidara Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, CDTX TTM cash from operations has changed by -$4.24M (-3.40%)